Dr. Lara Davis, MD
Claim this profileOHSU Knight Cancer Institute
Studies Sarcoma
Studies Tumors
15 reported clinical trials
45 drugs studied
Area of expertise
1Sarcoma
Stage III
Stage IV
advanced
2Tumors
Stage IV
Stage III
metastatic
Affiliated Hospitals
Clinical Trials Lara Davis, MD is currently running
INBRX-109
for Chondrosarcoma
This trial tests INBRX-109, a specially designed protein, in patients with a hard-to-treat type of bone cancer. The treatment helps the immune system target and kill cancer cells by attaching to a specific marker on these cells.
Recruiting0 awards Phase 26 criteria
Tazemetostat + Doxorubicin
for Sarcoma
The participants of this study will have advanced epithelioid sarcoma. Sarcoma is a cancer of the connective tissues, such as nerves, muscles and bones. Epithelioid sarcoma is an ultra-rare sarcoma of the soft-tissue. Part 1 of this trial will evaluate the safety and the level of the study drug that the study drug combinations can be tolerated (known as tolerability). It is also designed to establish a recommended study drug dosage for the next part of the study. Part 2 will evaluate and compare for each of the study drug combinations how long participants live without their disease getting worse. The study drug is called tazemetostat. The study will test tazemetostat in combination with doxorubicin compared to placebo (dummy treatment) in combination with doxorubicin. Doxorubicin is a current front line treatment for epithelioid sarcoma
Recruiting1 award Phase 312 criteria
More about Lara Davis, MD
Clinical Trial Related4 years of experience running clinical trials · Led 15 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Lara Davis, MD has experience with
- Regorafenib
- Tazemetostat
- Cyclophosphamide
- Biospecimen Collection
- TK216
- Nivolumab
Breakdown of trials Lara Davis, MD has run
Sarcoma
Tumors
Liposarcoma
Chondrosarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lara Davis, MD specialize in?
Lara Davis, MD focuses on Sarcoma and Tumors. In particular, much of their work with Sarcoma has involved Stage III patients, or patients who are Stage IV.
Is Lara Davis, MD currently recruiting for clinical trials?
Yes, Lara Davis, MD is currently recruiting for 5 clinical trials in Portland Oregon. If you're interested in participating, you should apply.
Are there any treatments that Lara Davis, MD has studied deeply?
Yes, Lara Davis, MD has studied treatments such as Regorafenib, Tazemetostat, Cyclophosphamide.
What is the best way to schedule an appointment with Lara Davis, MD?
Apply for one of the trials that Lara Davis, MD is conducting.
What is the office address of Lara Davis, MD?
The office of Lara Davis, MD is located at: OHSU Knight Cancer Institute, Portland, Oregon 97239 United States. This is the address for their practice at the OHSU Knight Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.